• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>China Distance Education Holdings Limited ADR

China Distance Education Holdings Limited ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

  2. Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

    Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

  3. Research and Markets: Global Market Report of DL -Methionine

    Research and Markets: Global Market Report of DL -Methionine

  4. China Distance Education Holdings to Participate in Upcoming Investor Conferences

    China Distance Education Holdings to Participate in Upcoming Investor Conferences

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.